ArticleScientific reports2026
Linking the cardiometabolic index to coronary heart disease in groups with Diabetes and Prediabetes.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In conjunction with National Health and Nutrition Examination Survey (NHANES) data, we explored the association between cardiometabolic index (CMI), a metabolic-related indicator, and coronary heart disease (CHD) in individuals living with diabetes and prediabetes. Specifically, we aimed to assess how CMI is associated with the odds of prevalent CHD in individuals with diabetes and prediabetes, and to determine whether this association holds true across various demographic subgroups within the population with diabetes and prediabetes. This study evaluated a sample of 17,286 individuals with diabetes or prediabetes across four NHANES spanning from 2001 to 2016. The principal outcome of the study was the prevalence of coronary heart disease, diagnosed using self-reported information obtained from participant questionnaires.The association between CMI and CHD prevalence in individuals with diabetes or prediabetes was assessed using logistic regression and subgroup analyses. The age (mean and standard deviation) among the enrolled participants was 56.29 ± 15.98 years.The CMI (mean and standard deviation) was − 0.262 ± 0.853, and out of 17,286 participants, 1,086 were diagnosed with CHD.A association between the CMI and CHD was found in multivariable logistical regression analysis (OR = 1.22, 95% CI, 1.12–1.33).Categorizing CMI into quartiles showed that participants in the highest quartile (Q4: 0.28 to 3.93) had 34% elevated odds of CHD relative to participants in the bottom quartile. (Q1: -3.53 to -0.86) (OR = 1.34, 95% CI: 1.07–1.69). This positive link was stable across different demographic subgroups. In individuals with diabetes or prediabetes, elevated CMI values are significantly connected to a higher odds of prevalent CHD, an association that remains consistent across diverse population subgroups.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.